Silent cerebral infarction predicts vascular events in hemodialysis patients  by Naganuma, Toshihide et al.
Kidney International, Vol. 67 (2005), pp. 2434–2439
Silent cerebral infarction predicts vascular events
in hemodialysis patients
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Silent cerebral infarction predicts vascular events in
hemodialysis patients.
Background. Cardiovascular disease is the leading cause of
death in hemodialysis (HD) patients. We have previously re-
ported a higher incidence of silent cerebral infarction (SCI) in
HD patients compared with the control group using MRI stud-
ies. In the present study, we examined whether or not SCI could
predict vascular events in HD patients.
Methods. Cranial magnetic resonance imaging (MRI) was
performed on 119 HD patients without symptomatic cere-
brovascular disease. SCI was detected by MRI, and the patients
were prospectively followed up. The end points of the study
were the incidence of major events related to vascular events
(cerebral events, cardiac events, and sudden deaths). We in-
vestigated the prognostic role of SCI in cerebral, cardiac, and
vascular events by using the Kaplan-Meier method and Cox
proportional hazards analysis.
Results. The prevalence of SCI was 49.6% in HD patients.
During a follow-up period of maximum 60 months, vascular
events, which included 13 cerebral events, 5 cardiac events, and
3 sudden deaths, occurred in 21 patients. The presence of SCI
was predictive for a higher cerebral and vascular morbidity com-
pared to the absence of SCI [18.6% (N = 11) vs. 3.3% (N = 2),
P = 0.0169, and 30.5% (N = 18) vs. 5.0% (N = 3), P = 0.0006,
respectively]. By multivariate Cox proportional hazards analy-
sis, SCI remained a powerful independent predictor of cerebral
and vascular events (hazard ratio for cerebral events 7.33, 95%
CI 1.27–42.25: for vascular events 4.48, 95% CI 1.09–18.41).
Conclusion. The findings of the present study indicate that
the presence of SCI is a new risk factor for vascular events in
HD patients.
Silent cerebral infarction (SCI) is thought to be an
underlying or concomitant condition of clinical subcor-
tical brain infarction or brain hemorrhage in the general
population [1]. In most cases, SCI is found as a lacunar
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infarction, the most common form of subcortical infarc-
tion, defined by Fisher as a small, deep cerebral infarction
caused by occlusion of small penetrating cerebral arter-
ies [2]. The lacunar infarction results from the arteriolo-
sclerotic change of cerebral arteries, which is related to
aging and is accelerated by hypertension [3]. From the
results of magnetic resonance imaging (MRI) studies,
Kobayashi et al [1] reported that the incidence of SCI
was 10.6% in 993 neurologically normal adults without
history of cerebrovascular disease. Howard et al [4] also
reported that the incidence of SCI was 11% using MRI
studies. The Hisayama community-based study showed
that the incidence of SCI was 12.9% [5]. SCI is consid-
ered an important risk factor for clinical cerebrovascular
disease in the general population [1].
We have previously reported a higher incidence of SCI
in hemodialysis (HD) patients compared with the control
group using MRI studies (48.8% vs. 9.6%, respectively)
[6]. It is also well known that HD patients have a much
higher incidence of cardiovascular disease than normal
populations [7–11]. In spite of the high incidence of SCI,
the clinical significance of SCI in HD patients has not
yet been elucidated. In the present study, we investigated
whether or not SCI is associated with clinical vascular
events.
METHODS
Study design
We performed a prospective cohort study to investigate
whether or not SCI is associated with clinical vascular
events.
Patients
The cohort consisted of 119 neurologically normal HD
patients in stable conditions who agreed to undergo MRI,
and were diagnosed with the presence or absence of SCI.
They were selected from a total of 175 HD patients, and
were enrolled in the trial between April 1998 and October
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Table 1. Characteristics of patients with and without SCIa
Total No SCI SCI
(N = 119) (N = 60) (N = 59) P valueb
Age years 56.0 ± 12.7 49.2 ± 12.8 62.9 ± 8.1 <0.0001
Males/females 84/35 43/17 41/18 NS
Hematocrit % 31.6 ± 3.4 31.7 ± 3.2 31.6 ± 3.6 NS
Systolic blood
pressure mm
Hg
152.0 ± 20.7 150.9 ± 24.3 153.0 ± 18.1 NS
Diastolic blood
pressure mm
Hg
77.8 ± 10.8 79.4 ± 11.7 76.7 ± 10.1 NS
Hypertension
No.
102 51 51 NS
Diabetes
mellitus No.
34 10 24 0.0070
Total cholesterol
mg/dL
155.5 ± 40.7 158.0 ± 40.9 153.8 ± 41.1 NS
Triglycerides
mg/dL
94.2 ± 53.7 104.1 ± 12.8 87.2 ± 52.1 NS
HDL cholesterol
mg/dL
41.2 ± 12.6 42.0 ± 14.0 40.3 ± 11.5 NS
Dyslipidemia
No.
15 4 11 NS
Ischemic heart
disease No.
20 3 17 0.0012
Smoking habit
No.
30 8 22 0.0051
Dialysis duration
years
6.0 ± 5.5 6.5 ± 5.3 5.4 ± 5.6 NS
Serum albumin
g/dL
3.8 ± 0.4 3.9 ± 0.4 3.8 ± 0.3 0.0334
Body mass index
kg/m2
21.3 ± 3.3 21.2 ± 3.3 20.5 ± 2.9 NS
Abbreviations are: SCI, silent cerebral infarction; HDL, high density
lipoprotein.
aPlus-minus values are mean ±SD, bSCI vs. no SCI.
2000. All subjects had no past history or symptoms of
strokes, transient ischemic attacks, and dementia based
on their self-reports as well as their medical records. We
prospectively followed these patients until March 2003.
The end points of this study were the incidence of ma-
jor events related to cardiovascular disease. Patients with
autosomal-dominant polycystic kidney disease, chronic
infection, chronic inflammatory disease, or malignant
disease were excluded at the beginning of this study.
Table 1 shows the patient characteristics in 119 HD pa-
tients. The patients with SCI were significantly older than
those without SCI. The prevalence of diabetes mellitus,
ischemic heart disease, and smoking habits were signifi-
cantly higher in patients with SCI than in patients without
SCI. In addition, serum albumin levels were significantly
lower in patients with SCI than in patients without SCI.
All HD patients received regular dialysis using the
high-flux cellulose-triacetate or polysulfone hollow-fiber
dialyzer three times per week in sessions lasting 3 to
4.5 hours. The dialysate was buffered bicarbonate and
contained 140 mmol/L sodium. The dialysate flow rate
was 500 mL/min, and blood flow ranged from 120 to 200
mL/min. The dry weight was individually determined for
each patient on the basis of post-HD cardiothoracic ratio,
atrial natriuretic peptide levels, and clinical observations,
such as presence of muscle cramps, general fatigue, thirst,
or hypotension during the HD session, and all patients
were maintained at their set dry weight. Informed con-
sent was obtained from all for participation in the study.
Vascular events
In the present study, we defined vascular events as
comprising cerebral events, cardiac events, and sudden
deaths. Cerebral events were brain infarction, brain hem-
orrhage, subarachnoid hemorrhage, transient ischemic
attack (TIA), and prolonged reversible ischemic neuro-
logic defect (PRIND). Cardiac events were myocardial
infarction, the need for coronary angioplasty or coronary
bypass surgery, and congestive heart failure. All these dis-
eases were diagnosed by standard clinical criteria. Sud-
den death was defined as a witnessed death that occurred
within one hour after the onset of acute symptoms, and
without evidence of accident or violence.
Risk factors
Hypertension was defined by the administration of an-
tihypertensive agents and/or a history of this disorder,
a systolic blood pressure greater than 140 mm Hg, or a
diastolic blood pressure greater than 90 mm Hg. Blood
pressure was determined at the end points of HD sessions
with a standard mercury sphygmomanometer and cuffs
adapted to arm circumference. The systolic blood pres-
sure was taken as the point of appearance of Korotokof
sounds, and the diastolic blood pressure as the point of
disappearance of the sounds.
Dyslipidemia was defined as present if the subject had
total cholesterol (TC) >220 mg/dL, triglyceride (TG)
>150 mg/dL, and high-density lipoprotein (HDL) choles-
terol <40 mg/dL, according to the criteria of the Japan
Atherosclerosis Society, or had received medical treat-
ment for hyperlipidemia. In HD patients, blood samples
were taken from the arterial line before HD sessions.
Ischemic heart disease (IHD) was defined as either
angina, history of myocardial infarction, coronary artery
bypass surgery, or percutaneous transluminal angioplasty.
Angina was diagnosed by exercise electrocardiography or
myocardial perfusion imaging.
Smoking habit was defined as those respondents who
currently smoked cigarettes.
Outcome
We collected the patients’ clinical outcome data by
reviewing all medical records directly. Concerning the
25 patients who moved out of our dialysis hospitals dur-
ing the follow-up period, all their outcome data were
obtained through questionnaire forms filled out by the
present attending physicians. All vascular events were
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diagnosed carefully by the attending physicians, who had
not been notified of this study. In cases that presumable
vascular events happened out of hospital, the patient’s
family was interviewed by telephone to ascertain the cir-
cumstances.
Magnetic resonance imaging
All participating patients had a brain MRI that used
a superconducting magnet at a field strength of 1.5 T
on proton density, T1-, and T2-weighted images in ax-
ial planes at 10 mm thick slices. Infarction was defined
as a focal area larger than 3 mm in diameter in both T1-
and T2-weighted images that was visible as low-signal in-
tensity areas on T1-weighted image and as high-signal
intensity areas on T2-weighted image. The MR images
were assessed independently by two neuroradiologists
who had not been notified of any clinical information.
Cases with inconsistencies were excluded from the study.
From 125 patients with MRIs taken, six cases with di-
agnostic inconsistencies were excluded, resulting in 119
cases in this cohort study.
Statistical analysis
All data are presented as the mean ± SD. Differences
between groups were examined by Student t tests. Cat-
egorical variables were compared using chi-square anal-
ysis. The risks for cerebral, cardiac, and vascular events
between patients with or without SCI were compared
using Kaplan-Meier analysis. Differences between the
groups were analyzed by the log-rank test. The indepen-
dent power of different variables to predict cerebral or
vascular morbidity was assessed using Cox proportional
hazards regression analysis. Gender and presence of hy-
pertension, diabetes mellitus, dyslipidemia, IHD, and SCI
were represented by dummy variables (1 = male, 0 =
female; 1 = presence, 0 = absence) in the analysis. The
value of P < 0.05 was considered statistically significant.
These results were obtained on a Macintosh computer us-
ing the Stat View V Statistical System (Cary, NC, USA).
RESULTS
Prevalence of SCI in HD patients
Fifty-nine patients (49.6%) had SCI. Among the 59
HD patients with SCI, 56 cases had lacunar infarction,
and three cases had cortical infarction.
Outcome
No patients received kidney transplantation during the
follow-up period. Seven patients who died of nonvascu-
lar diseases during this period (four infectious diseases
and three malignant diseases) were censored when they
died. Vascular events occurred in 21 patients (Table 2),
where 11 events were lethal. Cerebral events were ob-
Table 2. Details of the study subjects with clinical stroke onset
Subject/ Hemodialysis Interval
age/sex SCI duration years Event months
1/71/male 1 6.2 BI 55
2/63/female 1 3.0 CHFa 30
3/61/male 1 3.2 Sudden deatha 19
4/55/male 1 4.1 BHa 39
5/55/male 1 5.0 CBS 45
6/77/female 1 6.5 BHa 1
7/70/male 1 1.0 Sudden deatha 10
8/63/male 1 1.2 BI 25
9/63/male 1 22.8 BH 20
10/70/male 1 14.0 BHa 10
11/65/male 1 6.3 BI 63
12/51/male 1 1.3 BI 5
13/72/female 1 12.5 TIA 34
14/69/female 1 17.5 Sudden deatha 29
15/46/male 1 22.0 AMI 40
16/53/female 0 5.0 AMIa 35
17/68/male 1 6.1 BIa 36
18/69/male 1 10.1 BIa 45
19/53/female 0 14.3 TIA 43
20/70/male 1 24.9 AMIa 23
21/38/male 0 5.1 TIA 42
Abbreviations are: SCI, silent cerebral infarction (absent = 0, present = 1):
BI, brain infarction; CHF, congestive heart failure; BH, brain hemorrhage; BS,
coronary bypass surgery; TIA, transient ischemic attack; AMI, acute myocardial
infarction.
aCase of death.
served in 13 cases, namely, brain infarction (N = 6), brain
hemorrhage (N = 4), and TIA (N = 3), in which two
cases of cerebral infarction, and three of cerebral hem-
orrhage caused deaths. Cardiac events in five cases were
congestive heart failure (N = 1), coronary bypass surgery
(N = 1), and myocardial infarction (N = 3), where two
cases of myocardial infarction, and one case of conges-
tive heart failure were lethal. In addition, sudden death
happened in three cases. The mean follow-up periods to
cerebral, cardiac, and vascular events were 40.2 ± 12.2,
42.1 ± 10.8, and 39.3 ± 12.4 months, respectively (range
1 to 60 months).
Kaplan-Meier analyses based on the presence or ab-
sence of SCI for cerebral, cardiac, and vascular morbid-
ity are shown in Figures 1 to 3. The group with SCI had
a significantly higher cerebral morbidity than that with-
out SCI [18.6% (N = 11) vs. 3.3% (N = 2), P = 0.0169,
Fig. 1]. Although cardiac morbidity was also higher in
the patients with SCI than in those without SCI, there
was no significant difference [6.8% (N = 4) vs. 1.6% (N
= 1), P = 0.1659, Fig. 2]. The three sudden death cases
were all with SCI. Accumulating cerebral events, cardiac
events, and sudden deaths together, vascular morbidity
was significantly higher in the presence of SCI than in the
absence of SCI [30.5% (N = 18) vs. 5.0% (N = 3), P =
0.0006, Fig. 3].
Predictors of cerebral morbidity in HD patients (model 1)
Using univariate and multivariate Cox proportional
hazards analysis, 11 clinical variables, including SCI, were
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Fig. 1. Kaplan-Meier analysis of cumulative rate of cerebrovascular
event-free survival in hemodialysis patients stratified into two groups
with/without silent cerebral infarction.
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Fig. 2. Kaplan-Meier analysis of cumulative rate of cardiac event-free
survival in hemodialysis patients stratified into two groups with/without
silent cerebral infarction.
examined for predicting cerebral morbidity. By univari-
ate analysis, two variables (duration of HD and SCI) were
shown to be significant predictors of cerebral morbidity.
Moreover, multivariate analysis demonstrated that SCI
was a significant independent predictor. In the present
study, the relative risk ratio of SCI was 7.33 (95% CI
1.27–42.25) (Table 3).
Predictors of vascular morbidity in HD patients (model 2)
Using univariate and multivariate Cox proportional
hazards analysis, 11 clinical variables, including SCI, were
examined for predicting vascular morbidity. By univari-
ate analysis, four variables (age, duration of HD, IHD, and
SCI) were shown to be significant predictors of vascular
morbidity. Moreover, multivariate analysis demonstrated
that SCI was a significant independent predictor. In the
present study, the relative risk ratio of SCI was 4.48 (95%
CI 1.09–18.41) (Table 4).
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Fig. 3. Kaplan-Meier analysis of cumulative rate of vascular event-free
survival in hemodialysis patients stratified into two groups with/without
silent cerebral infarction.
When evaluating the association between hypertension
and vascular events, we examined a continuous variable
(blood pressure), as well as a categorical variable (pres-
ence of hypertension), but no association was found by
using either variable.
DISCUSSION
Cardiovascular disease is the leading cause of death
in HD patients [11]. It is well known that the increased
risk of cardiovascular disease is attributable to advanced
atherosclerotic vascular changes [12, 13]. Degrees of
atherosis and sclerosis have been evaluated noninvasively
by measuring the intima-media thickness of the carotid
artery (CA-IMT) and aortic pulse wave velocity (PWV),
respectively. Shoji et al [13] showed that aortic stiffness
is an independent predictor of cardiovascular deaths in
patients with ESRD. Nishizawa et al [12] showed that
increased CA-IMT is an independent predictor of car-
diovascular mortality in the HD population.
SCI is a clinical end-organ manifestation of arteri-
olosclerosis in the brain, as well as retinal arterial sclerosis
in eyes and renal sclerosis in kidneys [2, 3]. Atheroscle-
rosis or microemboli from large arteries and the heart is
not considered to be a major pathogenesis of lacunar SCI
[2, 3]. In a prospective study of the general population,
Kobayashi et al [1] reported that subjects with SCI were
considered at high risk for clinical cerebrovascular dis-
eases. However, there have been no studies reported as
to whether SCI is a risk factor for cerebrovascular disease
in HD patients.
In the present study, we showed that the group with
SCI had a significantly higher cerebral and vascular mor-
bidity than the group without SCI. The group with SCI
also tended to have a higher cardiac morbidity than that
without SCI. This is the first report to evaluate the pre-
dictive role of SCI for vascular events in HD patients. It
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Table 3. Univariate and mutivariate predictors of cerebral events in 119 hemodialysis patients
Univariate Multivariate
Variable Unit increase Hazard ratio (95% CI) P Hazard ratio (95% CI) P
SCI 5.22 (1.15–23.63) .030 7.33 (1.27–42.25) .026
Age 1 year 1.04 (0.99–1.09) NS 1.04 (0.98–1.11) NS
Duration 1 year 1.11 (1.02–1.20) .014 1.09 (0.98–1.20) NS
Sex 0.66 (0.21–2.00) NS 0.50 (0.09–2.77) NS
Ischemic heart disease 0.85 (0.18–3.88) NS 0.59 (0.11–3.08) NS
Diabetes mellitus 0.40 (0.09–1.82) NS 0.32 (0.05–1.97) NS
Hypertension 2.12 (0.28–16.33) NS 3.25 (0.37–28.55) NS
Dyslipidemia 0.83 (0.11–6.40) NS 0.89 (0.08–9.48) NS
Smoking habit 1.39 (0.42–4.53) NS 1.96 (0.45–8.52) NS
Serum albumin 1 g/dL 1.56 (0.30–7.98) NS 6.18 (0.47–81.98) NS
Body mass index 1 kg/m2 0.86 (0.70–1.06) NS 0.95 (0.74–1.22) NS
SCI, silent cerebral infarction; 95% CI, 95% confidence interval.
Table 4. Univariate and mutivariate predictors of vascular events in 119 hemodialysis patients
Univariate Multivariate
Variable Unit increase Hazard ratio (95% CI) P Hazard ratio (95% CI) P
SCI 6.50 (1.91–22.06) .002 4.48 (1.09–18.41) .038
Age 1 year 1.04 (1.00–1.08) .044 1.03 (0.98–1.08) NS
Duration 1 year 1.09 (1.02–1.16) .014 1.08 (0.99–1.17) NS
Sex 0.66 (0.27–1.06) NS 0.70 (0.19–2.58) NS
Ischemic heart disease 3.38 (1.33–8.23) .010 2.36 (0.82–6.80) NS
Diabetes mellitus 0.99 (0.38–2.60) NS 0.72 (0.21–2.41) NS
Hypertension 1.69 (0.39–7.27) NS 2.40 (0.52–11.02) NS
Dyslipidemia 1.12 (0.26–4.90) NS 0.86 (0.15–4.95) NS
Smoking habit 2.24 (0.93–5.43) NS 3.04 (0.95–9.75) NS
Serum albumin 1 g/dL 0.78 (0.21–2.93) NS 2.09 (0.29–15.12) NS
Body mass index 1 kg/m2 0.85 (0.73–1.00) NS 0.90 (0.74–1.10) NS
SCI, silent cerebral infarction; 95% CI, 95% confidence interval.
has been reported that SCI predicts the progression of
systemic atherosclerosis that is manifested in the conduit
arteries [14], suggesting the increased risk for vascular
events in the presence of SCI. It is most likely that sys-
temic arteriolosclerotic vascular changes are advanced in
HD patients with SCI, which may also increase the risk
of cardiac events as well as cerebral events.
Our multivariate analysis showed that SCI was a pow-
erful independent predictor of cerebral and vascular
events. In a cohort study of the general population, SCI
was shown to be an independent risk factor for clinical
stroke in multiple logistic regression analysis including
age, sex, and presence of hypertension, diabetes, alcohol
habits, and retinal arterial sclerosis [1], which is consistent
with our findings.
HD duration was also an independent predictor of
both cerebral and vascular events by our univariate anal-
ysis. This finding is consistent with the recent report by
Angela et al [15] that increased mortality is the conse-
quence of a prolonged dialysis duration, which may be
explained by HD duration-dependent vascular calcifica-
tion. Age and IHD were also independent predictors of
vascular events in our univariate analysis, as shown by
previous reports on the general population [16, 17] and
HD patients [12, 18, 19]. However, the impact of HD du-
ration, age, and IHD was not as strong as that of SCI,
and was no longer significant by our multiple regression
analysis.
It is well established that hypertension is an important
risk factor for clinical cerebral stroke and cardiovascu-
lar disease, both in the general population [17] and in
HD patients [7–10, 18]. However, hypertension was not
a significant risk factor for cerebral or vascular events in
our present study, where most of the hypertensive HD
patients had received long-term antihypertensive treat-
ments that may have had a beneficial effect on cerebral
and coronal arteries.
Because a relatively small sample size of our study lim-
ited the statistical power of the analysis, our study never
denies the other possible risk factors, such as hyperten-
sion or smoking. In addition, it should be noted that there
are the other dialysis-related cardiovascular risk factors
such as left ventricular hypertrophy, atherosclerosis (e.g.,
CA-IMT or PWV), or Kt/V that were previously reported
but not assessed in this study.
Thirteen cerebrovascular events we observed were
brain infarction, brain hemorrhage, and TIA, suggesting
that SCI may be an important marker for predicting both
ischemic stroke and hypertensive brain hemorrhage. All
six cases of brain infarction were the same lacunar infarc-
tion as SCI, and all four cases of brain hemorrhage were
typical hypertensive putaminal hemorrhage, which was
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thought to have resulted from arteriolosclerosis as well
as SCI. In comparison with Kobayashi’s observation [1]
that strokes occurring in subjects with SCI were ischemic
stroke (74%) and brain hemorrhage (26%), brain hem-
orrhage seemed to occur more frequently in HD patients
with SCI, which can be attributed to heparinization or
hemostatic disorders in HD patients [8, 9]. Therefore,
antiplatelet therapy in patients with SCI is controversial,
although antithrombotic drugs can reduce the recurrence
of brain infarction in subjects with brain infarction or
coronary heart disease [20]. There have been no data con-
cerning the effect of antithrombotic drugs on the primary
prevention of clinical stroke in patients with SCI.
CONCLUSION
The presence of SCI is a new risk factor for vascular
events in HD patients, and vascular complications should
be checked carefully for the HD patients with SCI. Be-
cause chronic renal failure, hypertension, smoking habits,
and aging are independent risk factors for SCI, as shown
in our previous cross-sectional study [6], HD patients
having high risks of SCI should be screened for SCI by
MRI, and hypertension and smoking habits should be
thoroughly controlled in HD patients.
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